Ignite Creation Date:
2024-05-05 @ 5:23 PM
Last Modification Date:
2024-10-26 @ 9:31 AM
Study NCT ID:
NCT00448240
Status:
TERMINATED
Last Update Posted:
2010-02-02
First Post:
2007-03-14
Brief Title:
Erlotinib Tarceva During First Line Standard Platinum Containing Chemo for Advanced Squamous Cell Head and Neck Cancer
Sponsor:
Organization:
Henry Ford Health System